Valproate Sodium: A Controlled Clinical Trial Including Monitoring of Drug Levels

Epilepsia

Volumn 18, Issue 2, 1977, Pages 141-148

  Gram, Lennart ^a   Wulff, Karl ^a   Rasmussen, Kurt E ^a   Flachs, Helga ^a   Würtz‐Jørgensen, Annelise ^a   Sommerbeck, Kurt W ^a   Løhren, Viggo ^a  

^a Epilepsy Departments and Laboratory ^*  (Denmark)

Author keywords

Antiepileptic p erties; Controlled clir; EEC; Serum levels; trial; Valproate sodium

Indexed keywords

EID: 84984517151     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1977.tb04462.x     Document Type: Article

References (25)

1. Le Dépakine dans le traitement de ľepilepsie essentielle ou idiopathique
2. Antikonvulsive Behandlung mit Dipropylessigsäure im Kindesalter
3. International Classification of Epileptic Seizures
4. Sodium valproate in treatment of epilepsy
5. The use of nonparametric methods in the statistical analysis of the two‐period change‐over design
6. Concentration of dipropylacetate in plasma
7. Klinische Erfahrungen mit einen neuen Antiepileptikum; Dipropylessigsäure
8. Clinical trials of anti‐epileptic drugs
9. Sodium di‐n‐propylacetate: Estimation of effective serum levels
10. Propriétés pharmacodynamiques de ľ'acide n‐dipropylacktique
11. Tables of critical values for the Pratt matched pair signed rank statistic
12. Etude EEG et clinique du Depakine chez de malades presentant des crises comitiales et/ou des troubles psychiques
13. Pharmacokinetics of di‐n‐propylacetate in epileptic patients
14. A clinical note on a new antiepileptic, Depakine®
15. Sodium di‐N‐propyl‐acetate (DPA) in the treatment of epilepsy
16. Valproate sodium: Evaluation of so‐called psychotropic effect. A controlled study
17. A double‐blind comparative trial of sodium di‐propylacetate and ethosuximide in epilepsy in children with special emphasis on pure petit mal seizures (in Japanese)
18. Gerin‐nungsveranderungen durch Dipropylessigsaure (Ergenyl)
19. Dipropylacetate (Depakine® Ergenyl®) in the treatment of epilepsy
20. Elevation of diphenylhydantoin and primidone serum concentration by addition of dipropylacetate, a new anticonvulsant drug
21. Clinical pharmacological aspects of valproate sodium